Prudential Financial’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $79.8K | Buy |
47,487
+4,000
| +9% | +$5.82K | ﹤0.01% | 2370 |
|
|
2026
Q1 | $57.4K | Buy |
43,487
+20,750
| +91% | +$37.1K | ﹤0.01% | 2297 |
|
|
2025
Q4 | $42.5K | Sell |
22,737
-12,947
| -36% | -$24.9K | ﹤0.01% | 2157 |
|
|
2025
Q3 | $45.7K | Hold |
35,684
| – | – | ﹤0.01% | 2344 |
|
|
2025
Q2 | $44.2K | Buy |
35,684
+15,062
| +73% | +$17.4K | ﹤0.01% | 2353 |
|
|
2025
Q1 | $24.3K | Buy |
20,622
+390
| +2% | +$598 | ﹤0.01% | 2241 |
|
|
2024
Q4 | $37K | Hold |
20,232
| – | – | ﹤0.01% | 2237 |
|
|
2024
Q3 | $34.4K | Buy |
20,232
+1,670
| +9% | +$2.74K | ﹤0.01% | 2671 |
|
|
2024
Q2 | $25.4K | Hold |
18,562
| – | – | ﹤0.01% | 2662 |
|
|
2024
Q1 | $69.6K | Sell |
18,562
-228
| -1% | -$1.33K | ﹤0.01% | 2563 |
|
|
2023
Q4 | $184K | Buy |
18,790
+628
| +3% | +$5.14K | ﹤0.01% | 2454 |
|
|
2023
Q3 | $152K | Sell |
18,162
-52,410
| -74% | -$599K | ﹤0.01% | 2420 |
|
|
2023
Q2 | $939K | Buy |
70,572
+53,360
| +310% | +$648K | ﹤0.01% | 1833 |
|
|
2023
Q1 | $76.9K | Buy |
17,212
+1,060
| +7% | +$10.5K | ﹤0.01% | 2467 |
|
|
2022
Q4 | $132K | Sell |
16,152
-292
| -2% | -$2.52K | ﹤0.01% | 2443 |
|
|
2022
Q3 | $73K | Buy |
16,444
+140
| +0.9% | +$803 | ﹤0.01% | 2533 |
|
|
2022
Q2 | $103K | Buy |
16,304
+1,229
| +8% | +$7.47K | ﹤0.01% | 2522 |
|
|
2022
Q1 | $137K | Buy |
15,075
+353
| +2% | +$4.06K | ﹤0.01% | 2537 |
|
|
2021
Q4 | $301K | Sell |
14,722
-2,531
| -15% | -$61.1K | ﹤0.01% | 2399 |
|
|
2021
Q3 | $508K | Buy |
17,253
+927
| +6% | +$27.5K | ﹤0.01% | 2135 |
|
|
2021
Q2 | $571K | Buy |
16,326
+891
| +6% | +$25.9K | ﹤0.01% | 2083 |
|
|
2021
Q1 | $514K | Buy |
15,435
+1,773
| +13% | +$62.1K | ﹤0.01% | 2119 |
|
|
2020
Q4 | $354K | Buy |
13,662
+1,540
| +13% | +$26.2K | ﹤0.01% | 2194 |
|
|
2020
Q3 | $120K | Sell |
12,122
-7,190
| -37% | -$41.4K | ﹤0.01% | 2353 |
|
|
2020
Q2 | $67K | Buy |
19,312
+8,820
| +84% | +$30K | ﹤0.01% | 2351 |
|
|
2020
Q1 | $32K | Sell |
10,492
-1,700
| -14% | -$6.96K | ﹤0.01% | 2314 |
|
|
2019
Q4 | $63K | Buy |
12,192
+210
| +2% | +$1.07K | ﹤0.01% | 2391 |
|
|
2019
Q3 | $62K | Sell |
11,982
-2,230
| -16% | -$12.5K | ﹤0.01% | 2376 |
|
|
2019
Q2 | $86K | Buy |
14,212
+1,650
| +13% | +$11.6K | ﹤0.01% | 2410 |
|
|
2019
Q1 | $91K | Buy |
12,562
+160
| +1% | +$1.16K | ﹤0.01% | 2381 |
|
|
2018
Q4 | $92K | Buy |
12,402
+2,220
| +22% | +$14.1K | ﹤0.01% | 2310 |
|
|
2018
Q3 | $55K | Sell |
10,182
-430
| -4% | -$1.84K | ﹤0.01% | 2397 |
|
|
2018
Q2 | $38K | Buy |
+10,612
| New | +$29.4K | ﹤0.01% | 2411 |
|
|
2016
Q4 | – | Sell |
-34,242
| Closed | -$307K | – | 2369 |
|
|
2016
Q3 | $307K | Buy |
34,242
+680
| +2% | +$5.68K | ﹤0.01% | 2128 |
|
|
2016
Q2 | $237K | Buy |
33,562
+3,900
| +13% | +$35.6K | ﹤0.01% | 2165 |
|
|
2016
Q1 | $252K | Buy |
29,662
+2,200
| +8% | +$21.6K | ﹤0.01% | 2147 |
|
|
2015
Q4 | $361K | Sell |
27,462
-32,000
| -54% | -$287K | ﹤0.01% | 2042 |
|
|
2015
Q3 | $218K | Buy |
+59,462
| New | +$291K | ﹤0.01% | 2111 |
|
Other funds holding PACB
AIM
NAMA
Prudential Financial's PACB Position: Q2 2026 in Review
Prudential Financial increased its Pacific Biosciences (PACB) stake by 9.2% in Q2 2026, buying an estimated $5.82K and bringing the position to 47,487 shares worth $79.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2370.
Prudential Financial first reported a position in PACB in Q3 2015 and has held it in 38 quarters since. The position peaked at $939K in Q2 2023. 223 funds tracked by Wall St. Rank hold PACB as of Q2 2026.
- Prudential Financial held 47,487 shares of Pacific Biosciences worth $79.8K as of Q2 2026.
- Prudential Financial bought 4,000 Pacific Biosciences shares in Q2 2026, an estimated $5.82K.
- Pacific Biosciences made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #2370 holding.
- Prudential Financial first reported a position in Pacific Biosciences in Q3 2015 and has held it in 38 quarters since.
- Prudential Financial's Pacific Biosciences position peaked at $939K in Q2 2023.
- 223 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2026.
Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.